Jay Rughani is a partner at Andreessen Horowitz, where he invests in healthcare technology.

Over the past 7 years, Jay has helped build the a16z Bio + Health practice and helped lead a16z’s investments in numerous ambitious companies, including Alchemy, Alleviate, Aradigm, Biodock, Counsel, Ferry, Inductive, Komodo, Leona, Midstream, Orchestra, Pearl, Tennr, Thatch, Thyme, Turquoise, and Valar.

Prior to joining a16z in 2018, Jay was an early team member at Flatiron, an electronic health record and real-world evidence company acquired by Roche for ~$2B. There, he helped to build some of the company’s first healthcare software and data products and later led numerous commercial partnerships through the company’s period of hypergrowth. Before Flatiron, he consulted for large healthcare and technology companies around the world at Deloitte, worked at Dealermatch (a seed-stage B2B marketplace later acquired by Cox Enterprises), and co-founded an unsuccessful startup with his college roommate.

Jay graduated from Emory University with a degree in Mathematics & Economics and grew up mostly in Tampa Bay, FL, apart from a three-year stint in boarding school in London, UK.